CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 201 enrolled
Drug / intervention
Symbicort Turbuhaler 160/4.5drug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00576316
NCT00576316Phase 4Completed

Symbicort Maintenance And Reliever Therapy - Experience in Real Life Setting in Malaysia - SMARTER Study

AstraZeneca·interventional·Posted Dec 19, 2007·Updated Dec 16, 2010

In Brief

A Phase 4 clinical trial evaluating Symbicort Turbuhaler 160/4.5 for Asthma. Completed, enrolled 201 participants across 1 site.

Detailed Summary

The purpose of the study is to evaluate the satisfaction level of patients using the Symbicort SMART approach for their asthma management.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAsthma
CountriesMalaysia
Collaborators--

Timeline

Phase 4CompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedDec 19, 2007
Enrollment StartJan 1, 2008
Study CompletionNov 1, 2008
TodayJul 2, 2026
Posted 18.5 years ago

Interventions

Symbicort Turbuhaler 160/4.5drug